Article
Structural consequences of tumor-derived mutations in p16INK4a probed by limited proteolysis.
Biochemistry - 21 May 2002
Zhang Bin, Peng Zheng-yu
Abstract excerpt
The cyclin-dependent kinase inhibitor p16(INK4a) (hereafter p16) functions as a multiple tumor suppressor. Mutations in p16, which are distributed throughout the entire protein, have been identified in a variety of human cancers and cancer-derived cell lines. It is unclear how tumor-derived mutations disrupt the structure and function of p16, especially since many of these mutations are located far away from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
